We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards ...

The combination will drive higher loan volume and long-term client relationships, while offering greater recurring revenue ...

Indianapolis: Indianapolis-based pharmaceutical giant Eli Lilly has faced a setback as the European Union's drug regulator ...

Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...

The National Football League (NFL) announced Novartis as its first-ever corporate pharmaceutical partner on March 13.

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...

A Nasdaq-listed pharmaceutical development company said it is investigating a cybersecurity incident following claims from the LockBit ransomware gang that data was stolen. A spokesperson for ...

Trump last week called out Ireland for luring pharmaceutical companies with tax breaks, contributing to a "massive deficit." White House officials did not respond to a request for comment.

Are pharmaceutical companies earning too much? Deciding whether pharmaceutical companies earn too much money is complicated. In this issue of JAMA, 2 reports take different approaches to the question.